Palavras-chave
diagnóstico
tratamento
Como Citar
Resumo
O câncer de pele é provocado pelo crescimento anormal e descontrolado das células que compõem a pele. Essas células se dispõem formando camadas e, de acordo com as que forem afetadas, são definidos os diferentes tipos de câncer. Este artigo tem por objetivo revisar sobre o câncer de pele. Trata-se de uma revisão integrativa utilizando como base de dados a BVS, a SciELO, o LILACS e o PubMed, nos últimos 5 anos. Foram avaliados 252 artigos sobre o tema com ênfase em uma síntese dos conhecimentos mais recentes e de maior consistência científica. Conclui-se que o câncer de pele requer grande atenção, desde sua prevenção até o diagnóstico final.
Referências
AHMED, B.; QADIR, M. I.; GHAFOOR, S. Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment. Critical Reviews in Eukaryotic Gene Expression, v. 30, n. 4, p. 291–297, 2020.
ALGARIN, Y. A. et al. Advances in Topical Treatments of Cutaneous Malignancies. American Journal of Clinical Dermatology, 28 set. 2022.
BAUMANN, B. C. et al. Management of primary skin cancer during a pandemic: Multidisciplinary recommendations. Cancer, v. 126, n. 17, p. 3900–3906, jun. 2020.
ČEOVIĆ, R. et al. Nonsurgical treatment of nonmelanoma skin cancer in the mature patient. Clinics in Dermatology, v. 36, n. 2, p. 177–187, mar. 2018.
CULLEN, J. K. et al. Topical treatments for skin cancer. Advanced Drug Delivery Reviews, v. 153, p. 54–64, jan. 2020.
DILDAR, M. et al. Skin Cancer Detection: A Review Using Deep Learning Techniques. International Journal of Environmental Research and Public Health, v. 18, n. 10, p. 5479, 20 maio 2021.
GRUBER, P.; ZITO, P. M. Skin Cancer. Disponível em: <https://pubmed.ncbi.nlm.nih.gov/28722978/>.
HORA, E. C. et al. Cross-cultural adaptation of the Skin Cancer Index into Brazilian Portuguese for patients with cervicofacial nonmelanoma skin cancer. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, v. 31, n. 10, p. 590, 23 set. 2023.
JINDAL, M. et al. Skin Cancer Management: Current Scenario and Future Perspectives. Current Drug Safety, v. 17, 13 abr. 2022.
JONES, O. T. et al. Recognising Skin Cancer in Primary Care. Advances in Therapy, v. 37, n. 1, p. 603–616, 16 nov. 2019.
PŁACHTA, I. et al. Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation. International Journal of Molecular Sciences, v. 22, n. 9, p. 4759, 30 abr. 2021.
PEREIRA SHIMADA, G. D. et al. Time-to-treatment initiation for cutaneous melanoma reflects disparities in healthcare access in Brazil: a retrospective study. Public Health, v. 210, p. 1–7, set. 2022.
SHARON, E. et al. Laser Treatment for Non-Melanoma Skin Cancer: A Systematic Review and Meta-Analysis. American Journal of Clinical Dermatology, v. 22, n. 1, p. 25–38, 15 set. 2020.
SILVEIRA, C.; MAUAD, E. Analysis of a decade of skin cancer prevention using a mobile unit in Brazil. Rural and Remote Health, 15 maio 2019.
TIBA, A. P. L. et al. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer: a pilot study in the Brazilian population. International Journal of Dermatology, v. 61, n. 6, 4 set. 2021.
TREJIĆ, S. et al. Diagnostic Accuracy of Skin Cancer by Family Physicians. The Journal of the American Board of Family Medicine, v. 34, n. 5, p. 984–990, set. 2021.
VILLANI, A. et al. New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma. Advances in Therapy, 28 jan. 2022.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Idelbrando Araújo Lima Júnior, Amanda das Virgens Lisboa, Maurício Gabriel Gonçalves Ferreira, Ademilton Maximiano de Paula Júnior , Camila Jardim Gomes , Jussara Aparecida de Souza, Ozarlan Michel Pereira de Oliveira, Gleiciane Ramos Vaz , Sabrina da Silva Santos , Vitória Matos Bezerra, Maria Elvira Calmon de Araújo Mascarenhas, João Victor Paranaguá Caram Salvadego